Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2025-12-25 @ 12:22 AM
NCT ID:
NCT00633958
Eligibility Criteria:
Inclusion Criteria:
* Pediatric patients with newly diagnosed central nervous system tumors undergoing planned surgical resection within 21 days.
* Patients should be \< 21 years of age at the time of diagnosis.
* Patients should be capable of achieving imaging without the need for sedation or anesthesia.
* Karnofsky Performance Status ≥ 50. For infants, the Lansky play scale ≥ 50% can be substituted.
* Patients must not be pregnant or nursing.
* Signed Informed Consent.
* Patients receiving steroids and/or anti-seizure medications are eligible for this study.
Exclusion Criteria:
* Prior radiation therapy and/or chemotherapy are not permitted.
* Active infection
* Pregnancy or breast feeding
* Serious concurrent medical illness
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
21 Years
Study:
NCT00633958
Study Brief:
Protocol Section:
NCT00633958